| 1. |
|
|
| 2. |
- Gazzotti, Stefano, et al.
(författare)
-
DOX mediated synthesis of PLA-co-PS graft copolymers with matrix-driven self-assembly in PLA-based blends
- 2022
-
Ingår i: European Polymer Journal. - : Elsevier BV. - 0014-3057 .- 1873-1945. ; 170, s. 111157-
-
Tidskriftsartikel (refereegranskat)abstract
- Intriguing phase morphology was formed through self-assembly of polylactide-polystyrene (PLA-co-PS) graft copolymers blended with polylactide (PLA). PLA-co-PS graft copolymers were synthesized by exploiting a styrene-functionalized 1,3-Dioxolan-4-one (StyDOX) monomer through a two-step procedure and their structure was confirmed. Different amounts of PLA-co-PS and commercial PLA were solution cast to blend films. Etching of amorphous PLA revealed the presence of spherical micrometer sized domains dispersed within the films, arising from the self-assembly behavior of PLA-co-PS caused by the immiscibility of PS-grafts in the PLA matrix. EDS and IR imaging analyses further revealed that these microspheres were characterized by a PS-rich core opposed to the PLA-rich outer shell, which is expected to be miscible and able to form favorable interactions with the PLA matrix. PLA/PS blends were also prepared with different loadings of PLA-co-PS. The ability of PLA-co-PS to compatibilize the two phases was assessed through rheological analyses. Finally, the possibility to chemically recycle the copolymer was evaluated.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Mohanty, A. K., et al.
(författare)
-
Sustainable polymers
- 2022
-
Ingår i: Nature Reviews Methods Primers. - : Springer Nature. - 2662-8449. ; 2:1
-
Tidskriftsartikel (refereegranskat)abstract
- Sustainable polymers are materials derived from renewable, recycled and waste carbon resources and their combinations, which at the end of life can be recycled, biodegraded or composted. Sustainable polymers also exhibit reduced environmental impact throughout their life cycle. This Primer presents an overview of the research in and potential of sustainable polymers, with a focus on their life cycle, synthetic routes from renewable carbon feedstocks, production, material characterization, applications, end of life, data reproducibility and limitations faced, and provides a brief outlook. The Primer also briefly covers other carbon feedstocks such as carbon dioxide and wastes, including agricultural and woody residues. Although still in their infancy, new sustainable polymers are already finding applications in packaging, automotive parts and 3D printing. This Primer also discusses the headwinds facing the adoption of sustainable polymers, including complexities of recycling and composting, manufacturing scale-up, data reproducibility, deposition and potential solutions. Development of sustainable polymers will accelerate the age of sustainable polymers and create a truly circular economy for plastics by reducing production and use of virgin plastics from finite resources.
|
|
| 6. |
- Svensson, Sofie, et al.
(författare)
-
Turning food waste to antibacterial and biocompatible fungal chitin/chitosan monofilaments
- 2022
-
Ingår i: International Journal of Biological Macromolecules. - : Elsevier BV. - 0141-8130 .- 1879-0003. ; 209, s. 618-630
-
Tidskriftsartikel (refereegranskat)abstract
- Here, cell wall of a zygomycete fungus, Rhizopus delemar, grown on bread waste was wet spun into monofilaments. Using the whole cell wall material omits the common chitosan isolation and purification steps and leads to higher material utilization. The fungal cell wall contained 36.9% and 19.7% chitosan and chitin, respectively. Solid state NMR of the fungal cell wall material confirmed the presence of chitosan, chitin, and other carbohydrates. Hydrogels were prepared by ultrafine grinding of the cell wall, followed by addition of lactic acid to protonate the amino groups of chitosan, and subsequently wet spun into monofilaments. The monofilament inhibited the growth of Bacillus megaterium (Gram+ bacterium) and Escherichia coli (Gram- bacterium) significantly (92.2% and 99.7% respectively). Cytotoxicity was evaluated using an in vitro assay with human dermal fibroblasts, indicating no toxic inducement from exposure of the monofilaments. The antimicrobial and biocompatible fungal monofilaments, open new avenues for sustainable biomedical textiles from abundant food waste.
|
|
| 7. |
- Taskinen, M. R., et al.
(författare)
-
Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations
- 2022
-
Ingår i: Jci Insight. - : American Society for Clinical Investigation. - 2379-3708. ; 7:19
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND. Apolipoprotein C-III (apoC-III) is a regulator of triglyceride (TG) metabolism, and due to its association with risk of cardiovascular disease, is an emergent target for pharmacological intervention. The impact of substantially lowering apoC-III on lipoprotein metabolism is not clear.METHODS. We investigated the kinetics of apolipoproteins B48 and B100 (apoB48 and apoB100) in chylomicrons, VLDL1, VLDL2, IDL, and LDL in patients heterozygous for a loss-of-function (LOF) mutation in the APOC3 gene. Studies were conducted in the postprandial state to provide a more comprehensive view of the influence of this protein on TG transport.RESULTS. Compared with non-LOF variant participants, a genetically determined decrease in apoC-III resulted in marked acceleration of lipolysis of TG-rich lipoproteins (TRLs), increased removal of VLDL remnants from the bloodstream, and substantial decrease in circulating levels of VLDL1, VLDL2, and IDL particles. Production rates for apoB48-containing chylomicrons and apoB100-containing VLDL1 and VLDL2 were not different between LOF carriers and noncarriers. Likewise, the rate of production of LDL was not affected by the lower apoC-III level, nor were the concentration and clearance rate of LDL-apoB100.CONCLUSION. These findings indicate that apoC-III lowering will have a marked effect on TRL and remnant metabolism, with possibly significant consequences for cardiovascular disease prevention. TRIAL REGISTRATION. ClinicalTrials.gov NCT04209816 and NCT01445730.
|
|
| 8. |
- Björnson, Elias, 1988, et al.
(författare)
-
Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects
- 2020
-
Ingår i: Journal of Internal Medicine. - : Wiley. - 0954-6820 .- 1365-2796. ; 288:4, s. 422-438
-
Tidskriftsartikel (refereegranskat)abstract
- Background Renewed interest in triglyceride-rich lipoproteins as causative agents in cardiovascular disease mandates further exploration of the integrated metabolism of chylomicrons and very low-density lipoproteins (VLDL). Methods Novel tracer techniques and an integrated multi-compartmental model were used to determine the kinetics of apoB48- and apoB100-containing particles in the chylomicron and VLDL density intervals in 15 subjects with a wide range of plasma triglyceride levels. Results Following a fat-rich meal, apoB48 appeared in the chylomicron, VLDL1 and VLDL2 fractions in all subjects. Chylomicrons cleared rapidly from the circulation but apoB48-containing VLDL accumulated, and over the day were 3-fold higher in those with high versus low plasma triglyceride. ApoB48-containing particles were secreted directly into both the chylomicron and VLDL fractions at rates that were similar across the plasma triglyceride range studied. During fat absorption, whilst most triglyceride entered the circulation in chylomicrons, the majority of apoB48 particles were secreted into the VLDL density range. Conclusion The intestine secretes apoB48-containing particles not only as chylomicrons but also directly into the VLDL1 and VLDL2 density ranges both in the basal state and during dietary lipid absorption. Over the day, apoB48-containing particles appear to comprise about 20-25% of circulating VLDL and, especially in those with elevated triglycerides, form part of a slowly cleared 'remnant' particle population, thereby potentially increasing CHD risk. These findings provide a metabolic understanding of the potential consequences for increased CHD risk when slowed lipolysis leads to the accumulation of remnants, especially in individuals with hypertriglyceridemia.
|
|
| 9. |
|
|
| 10. |
|
|
